Form4insider filings, from the source

SEC Form 4 · accession 0001709954-26-000012

MapLight Therapeutics, Inc. · MPLT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jonathan Gillis
Officer — CAO and Interim CFO
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 6:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001770069

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Voting Common StockF1,F2Aug 17, 2026A6,020$0.00A150,260D
Voting Common StockF3,F2Aug 17, 2026A2,222$0.00A152,482D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F4$11.245Aug 17, 2026A24,455A—Aug 16, 2036Voting Common Stock24,45524,455D
Employee Stock Option (Right to Buy)F5$11.245Aug 17, 2026A2,813A—Aug 16, 2036Voting Common Stock2,8132,813D

Explanation of responses